Healthcare Holding B.V. Gilde Sells 20,034 Shares of Shoulder Innovations (NYSE:SI) Stock

Shoulder Innovations, Inc. (NYSE:SI) major shareholder Healthcare Holding B.V. Gilde sold 20,034 shares of the firm’s stock in a transaction that occurred on Friday, July 31st. The shares were sold at an average price of $22.73, for a total transaction of $455,372.82. Following the completion of the sale, the insider directly owned 2,332,203 shares in the company, valued at $53,010,974.19. This represents a 0.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The stock was sold at an average price of $23.36, for a total transaction of $659,803.20.

Shoulder Innovations Price Performance

Shares of NYSE:SI traded down $0.33 during trading on Monday, reaching $22.41. The company had a trading volume of 65,637 shares, compared to its average volume of 92,187. The company has a fifty day moving average of $19.19 and a two-hundred day moving average of $15.79. The company has a current ratio of 11.81, a quick ratio of 10.04 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $464.89 million and a P/E ratio of -0.13. Shoulder Innovations, Inc. has a 12 month low of $10.92 and a 12 month high of $24.59.

Shoulder Innovations (NYSE:SI) last announced its earnings results on Wednesday, May 13th. The company reported ($0.41) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.44) by $0.03. The company had revenue of $16.71 million during the quarter. Shoulder Innovations had a negative net margin of 81.78% and a negative return on equity of 35.11%. Equities research analysts forecast that Shoulder Innovations, Inc. will post -1.67 earnings per share for the current year.

Analysts Set New Price Targets

SI has been the subject of a number of research reports. Piper Sandler reiterated an “overweight” rating and issued a $19.00 price objective (up from $18.00) on shares of Shoulder Innovations in a report on Friday, May 8th. Weiss Ratings restated a “sell (d-)” rating on shares of Shoulder Innovations in a research report on Monday, June 29th. Finally, UBS Group assumed coverage on Shoulder Innovations in a research note on Tuesday, July 28th. They issued a “buy” rating and a $27.00 target price for the company. Six research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $22.00.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Sectoral Asset Management Inc. increased its holdings in shares of Shoulder Innovations by 14.4% in the fourth quarter. Sectoral Asset Management Inc. now owns 492,435 shares of the company’s stock worth $7,042,000 after buying an additional 62,153 shares during the period. Deerfield Management Company L.P. bought a new stake in shares of Shoulder Innovations in the 3rd quarter valued at about $6,056,000. Alyeska Investment Group L.P. purchased a new stake in Shoulder Innovations during the 3rd quarter valued at about $5,667,000. Roubaix Capital LLC grew its position in Shoulder Innovations by 61.9% during the 1st quarter. Roubaix Capital LLC now owns 257,121 shares of the company’s stock worth $3,736,000 after acquiring an additional 98,305 shares during the last quarter. Finally, Vanguard Group Inc. bought a new position in Shoulder Innovations during the 3rd quarter worth approximately $1,836,000.

Shoulder Innovations Company Profile

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.